Surgical Oncology

Raphael E. Pollock

ISBN 10: 0792399005 / ISBN 13: 9780792399001

Edité par Springer US, Springer US, 1997

A propos de cet article

Druck auf Anfrage Neuware - Printed after ordering - This volume attempts to demonstrate that increasingly sophisticated diagnostic and staging approaches are helping to move chemotherapy and radiotherapy into the preoperative neoadjuvant setting. This fundamental alteration is based on the awareness that even early-stage solid tumor disease is frequently systemic at the time of presentation, at least on a subclinical level. Although the primary tumor may be controllable by surgery with radiotherapy, the uncontrolled distant disease ultimately determines patient survival. The other perspective driving the neoadjuvant approach is an emerging awareness that, for most solid tumor systems, neoadjuvant treatment responses can facilitate less mutilating surgery with comparable levels of local disease control. These unifying concepts have reached increasing acceptance and are being extended via the crucible of clinical trials. Surgical Oncology seeks to impart a sense of what is pertinent in the rapidly evolving field of surgical oncology. By identifying new developments in each solid tumour site, the reader will gain an anticipatory sense of where the discipline of surgical oncology is headed.

N° de réf. du vendeur 9780792399001

Détails bibliographiques

• Titre: Surgical Oncology
• Éditeur: Springer US, Springer US
• Date de parution: 1997
• Langue: anglais
• ISBN à 10 chiffres: 0792399005
• ISBN à 13 chiffres: 9780792399001
• Reliure: Buch
• État de l'article: Neu
• Dimensions: 241 L x 160 H x 29 P (en millimètres) 241 millimètres de largeur par 160 millimètres de hauteur par 29 millimètres de profondeur
• Poids: 817 grammes

A propos de ce titre

Synopsis

Among the standard oncology modalities, surgical oncology is singular in that it lacks a separate board certification or even an added qualification mecha- nism. 'Card-carrying' surgical oncologists are certified by the American Board of Surgery, as are all other general surgeons. What distinguishes the surgical oncologist is a set of cognitive skills rather than a specific armamentarium of surgical techniques. This different conceptual framework is derived from ex- tensive additional training that leads to an in-depth understanding of the natural history and biologic behavior of the various solid tumor systems. Equipped with this perspective, the surgical oncologist is particularly well positioned to integrate the various available therapeutic modalities into a coherent care program for the solid tumor patient. As a central theme, the chapters of this book demonstrate that increasingly sophisticated diagnostic and staging approaches are helping to move chemo- therapy and radiotherapy into the preoperative neoadjuvant setting. This fundamental alteration is based on the awareness that even early-stage solid tumor disease is frequently systemic at the time of presentation, at least on a subclinical level. And although the primary tumor may be controllable by surgery with radiotherapy, the uncontrolled (and initially clinically unappar- ent) distant disease ultimately determines patient survival. The other perspec- tive driving the neoadjuvant approach is an emerging awareness that for most solid tumor systems, neoadjuvant treatment responses can facilitate less muti- lating surgery with comparable levels of local disease control.